Amneal Pharmaceuticals
AMRX
AMRX
176 hedge funds and large institutions have $651M invested in Amneal Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 68 increasing their positions, 47 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
15% more funds holding
Funds holding: 153 → 176 (+23)
0.73% less ownership
Funds ownership: 35.78% → 35.05% (-0.73%)
2% less capital invested
Capital invested by funds: $666M → $651M (-$14.9M)
Holders
176
Holding in Top 10
2
Calls
$4.53M
Puts
$503K
Top Buyers
| 1 | +$9.34M | |
| 2 | +$8.56M | |
| 3 | +$4.97M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$4.17M |
| 5 |
Millennium Management
New York
|
+$2.96M |
Top Sellers
| 1 | -$55.8M | |
| 2 | -$8.66M | |
| 3 | -$2.85M | |
| 4 |
D.E. Shaw & Co
New York
|
-$2.67M |
| 5 |
BGIM
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
-$2.51M |